- Front Page
- About
- Multimedia
- Submit
- Archive
2021 PDA Honor Awards: VanTrieste, Korczynski and Smith Awards
You Had Micro Questions, FDA Had Big Answers
Parenteral Packaging 2022: A Q&A with the Conference Chairs
Accelerated COVAX Approvals Maintained Rigorous Review Process
Merck Streamlines Quality Management with the Cloud
Glenn E. Wright Starts as PDA President & CEO in March 2023; Richard M. Johnson to Retire
PDA's Successful Return to In-Person Meetings
Initial Evaluation Roadmap for Modern Microbial Methods
Voices of the Board: The PDA Foundation
PDA is Updating Its Membership Structure!
Rich Levy Retires; Shanker Gupta to serve as Acting JPST Editor
How Ergonomics & Cleaning Reduce Injuries, Contamination in Micro QC Workflows
The Role of Peer Review in the Success of the PDA Journal of Pharmaceutical Science and Technology
Science-Based Approach to CCI Met with Enthusiasm
Long-Distance Leadership: Managing a Remote or Hybrid Workforce the Right Way
PDA "Just Right" for John Shabushnig
Chair's Message: Busy Week in Dallas Marks Return to Live Events
PDA Letter Article of the Year
Guest Editorial: What Might Have Been
PDA Visual Inspection Forum Returns; Lands in Berlin in 2022
A supplier's perspective: How can EU GMP Annex I be integrated into the manufacturing of components for container closure systems?
President's Message: 2021, A Challenging Year for Everyone
Past Leader Spotlight: Nikki Mehringer, Volunteered to Volunteer
Zero Defect – A Competitive Advantage
Taking the Fear Out of Contamination: Surfaces, Water, and Air, Oh My!
2021 was a Challenging Year
5 Agreements for Your Future Culture
PDA COVID-19 Task Force
Inspection Resources Hot Topic during 'Ask the Regulators' at PDA/FDA JRC
PDA Assists EMA with Survey about Supply Challenges Related to the Availability of Single-Use-System Components
Contamination Control Strategies: You have questions, we have answers
Past Leader Spotlight: Rebecca Devine from FDA CBER to PDA Chair
PDA In Print: Management of Nonconformances for Temperature-Sensitive Products
Thanks, Science!
Annex 1 and the New Revision — Setting New Expectations
PDA’s Honor Awards Program
Zero-Particulates Goal Promotes Continuous Improvement
Three Past Chairs Discuss PDA Careers
How to Measure Quality Management Maturity
NEPDA Awards Its 2021 Scholarships
Approaches to Data Integrity Assurance: 2021 Workshop
COVID-19 Puts Focus on Airborne Virus and Pathogenic Microorganism Detection Methods
COVID-19 Related Shortages of Manufacturing Components — There is a Way Through!
COVID-19 and the Need for an LAL Alternative
My Journey to Japan — Sort Of
Four Scenarios of Regulatory Relief from PAS and CBE-30 for CCS and Component Changes
PDA in Print: Planning for Effective Use of Technology for Remote Inspections
Guest Editorial: Covid-19 Vaccine and High Stakes of Quality
PDA’s Critical Role in Advancing Manufacturing Science
How close are we to closed processing?
The PDA Community Remembers Long-Time Member and Publisher, Amy Davis
Past Leader Spotlight: Fred Carleton, President 1977-1979, Executive Director 1988-1991
Virtual EMA Multistakeholder Meeting on Drug-Device Combination Products
PDA Summer Reading 2021
PDA Southern California Chapter Congratulates PDA Student Chapter Grads
Past Leader Spotlight: Nathan Kirsch, PDA President 1965-1966
Modern Quality Professional, Part 3: Using the Scoring System
President’s Message: PDA Mid-Year Update
Breaking Down Computer Systems Validation in a Regulated Environment
New Frontiers in Developing and Manufacturing Vaccines
Early Career Professionals – Kickstart Your Career with PDA!
Call for Volunteers: The PDA Foundation
Modern Quality Professional, Part 2: The Case Studies
Flexibility—the Future of Manufacturing
Why Industry Cannot Just “Move Away" from the Dye Ingress Test
Pop Quiz: Which Academic Institutions should PDA Work With?
Remote Audits and Inspections May Be Here to Stay: PDA’s Task Force Aims to Help
COVID-19 and the Sustainability of the LAL Supply
Happenings at the 2021 PDA Singapore Chapter Annual General Meeting
The Modern Quality Professional Development Tool, Part 1
The Two aspects of Visual Inspection: Process and Technology
Nominations for PDA Board of Directors Accepted until May 10
PDA in Print: Quality by Design— An Indispensable Approach to Accelerate Biopharmaceutical Product Development
PDA Annual Meeting and Honor Awards Ceremony Begins 75th Anniversary Celebration
The Role of Current GMPs in COVID-19 Vaccine Production
In Print: PDA 2021 Post-Approval Change Issues and Impacts Survey
Visual Inspection Training at PDA
FDA Initiatives Drive 21st Century Advanced Manufacturing Technologies
SoCal Chapter Poster Finalist: Launching Drugs During COVID-19
The Value of Membership
Think Big, Leverage and Cooperate to Get COVID-19 Vaccines to People Faster
Supporting Early Career Professionals: How the Southern California Chapter Does It
Parenteral Packaging 2021: A Q&A with Conference Chairs
Voices of the Board: What has the year 2021 in store for us?
President’s Message: A Year Like No Other
The Moldy Nightmare: Questions and Answers, Part 2
Accelerating Biopharmaceutical Innovation in Health Emergencies
A Unique Year of Hidden Treasures
The Moldy Nightmare: Questions and Answers, Part 1
Facilitating Continual Improvement, Innovation, and Reducing Drug Shortages through Enhanced Science and Risk-based PACs
ANNEX 1 Revision Task Force Update
Think Globally, Work Virtually in the Era of COVID-19: The Future of Biotech Success
Getting Closer to AI Adoption in the Pharmaceutical Industry
Publishing by the Numbers: An End of an Era
Worried about the availability of primary packaging for the COVID Vaccine? It’s a logistics challenge, not a supply challenge
5 Steps of Design Thinking
Continued Process Verification: Reacting to Data Signals
Keeping Biopharma’s Essential Services Lifeline Afloat during COVID
Injectable Combination Product Integrated Development: A PDA Live eLearning Course
